IFAM
PACB icon

Institutional & Family Asset Management’s Pacific Biosciences PACB Stock Holding History

Institutional & Family Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed – – 891
2021
Q3 		$0 Sell
8
-6
-43% -$178 ﹤0.01% 958
2021
Q2 		$0 Buy
+14
New +$407 ﹤0.01% 995

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Institutional & Family Asset Management's PACB Position: Q4 2021 in Review

Institutional & Family Asset Management sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 8 shares.

Institutional & Family Asset Management first reported a position in PACB in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2021. 256 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • Institutional & Family Asset Management reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • Institutional & Family Asset Management sold 8 Pacific Biosciences shares in Q4 2021.
  • Institutional & Family Asset Management first reported a position in Pacific Biosciences in Q2 2021 and held it in 2 quarters.
  • Institutional & Family Asset Management's Pacific Biosciences position peaked at $0 in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on Institutional & Family Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.